Skip to main content
20 Pharmacy and Drugs Act Nc.12 2001 (a) details of the composition of the drug, and (b) copies of any descriptive matter published or proposed to be published in relation to the drug. (2) No disclosure of infonnation furnished under this section shaH be made without the consent of the person by whom it was furnished. Power to prohibit sale of proprietary drug. 34. (1) The Board may prohibit the sale of a proprietary drug if in its opinion:­ (a) claims are made for the drugs \vhich are unjustified: or (b) details of the composition of the drug furnished under this Act differ substantially from those disclosed on an analysis of samples by a laboratory approved by the Board. Descriptive matter published in relation toa propriet9rY drug must be in English and should not differ substantially from that contained in copies furnished to the Board in relation to ~e drug under section 33 and the Board may prohi bi t the .sale of any drug, in respect of which it is satisfIed that this subsectiorthas not been complied with. (2) Control of publication of deseri pti ve matter. lS. (1) Subject to this section, no person shall, by way of advertisement, publish or cause to be published in relation to any drug or service, descriptive matter calculated to lead to the use of that drug or servIce: ­ (a) for the prevention or treatment of anydisease specified in the Second Schedule; or (b) for the purpose of tenninating or influencing the course of human pregnancy; or (c) for any purpose relating to human sexual intercourse. I l I f

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents